by Bruce Sylvester – More than half of patients with metastatic melanoma treated with the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab have achieved durable tumor… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
by Peter Mas Mollinedo – Investigators report that the link between asthma and early childhood use of acetaminophen or ibuprofen could be the result of underlying respiratory infections,… read more.
The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete’s performance and give people who use it an unfair advantage… read more.
Results of late breaking trials presented at Heart Failure 2013. Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced… read more.
Erasmus virus resets cells’ genes and causes breathing distress and kidney failure. A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell… read more.
Low doses of the opioid antagonist naltrexone may relieve pain associated with fibromyalgia compared with placebo by targeting the immune pathway of pain, researchers said.
The pain-relieving efficacy of the buprenorphine transdermal medication system didn’t seem to be altered by a patient’s body mass, researchers said.
Most currently available osteoporosis drugs like denosumab are antiresorptive: they curb bone loss by blocking the action of cells that break down bone (osteoclasts) during the normal process… read more.
World Health Matters (Japan) by Gary Finnegan – Addiction may result from abnormal brain circuitry in the frontal cortex, the part of the brain that controls decision-making, according… read more.
EMA Highlights by Gary Finnegan – The number of clinical trials taking place in Europe and North America continues to fall as research activity in Africa, Asia and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
